Literature DB >> 807634

The molecular basis of self-association of IgG-Rheumatoid factors.

R M Pope, D C Teller, M Mannik.   

Abstract

The intermediate complexes, sedimenting between 19S and 6.6S components of normal serum on analytical ultracentrifugation, were purified from plasma of three patients with rheumatoid arthritis. Sequential gel filtration and removal of contaminants by agarose-antibody immunoadsorbents were employed for purification of these complexes. The isolated complexes from the three patients consisted of IgG with k and lambda light chains. Sedimentation equilibrium ultracentrifugation experiments showed that the isolated complexes underwent concentration-dependent self-association, whereby the smallest detectable molecular species had a molecular weight of 292,000. These IgG dimers were formed by self-association of IgG-rheumatoid factors, since nearly all F(ab) fragments, prepared from the isolated complexes by pepsin digestion, bound to normal IgG. The association constants for the interaction between normal IgG and one binding site of the F(ab) fragments were about 10-5 liters/mole. Since a cyclic structure with two antigen-antibody bonds was thought to form in the self-association of two IgG-rheumatoid factors, the association constant for dimer formation was calculated to be 10-10 liters/mole. The preferential self-association of IgG-rheumatoid factor was supported by the observation that monomeric normal human IgG did not replace the IgG-rheumatoid factor when the complexes were dissociated and reformed in the presence of excess normal IgG. The self-association of IgG-rheumatoid factors may be a general phenomenon in rheumatoid arthritis, as suggested by the observations of other investigators.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 807634

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Autoantibodies as diagnostic tool in juvenile connective tissue diseases.

Authors:  E M Egeskjold
Journal:  Indian J Pediatr       Date:  1989 May-Jun       Impact factor: 1.967

2.  The effect of human IgM rheumatoid factor on renal glomerular immune complex deposition in passive serum sickness in the mouse.

Authors:  P M Ford; I Kosataka
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

3.  On the composition of IgG anti-IgG immune complexes.

Authors:  J Steensgaard; A S Johansen; C Jacobsen
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

4.  Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue.

Authors:  M M Taylor-Upsahl; T G Abrahamsen; J B Natvig
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

5.  Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies.

Authors:  Nirmal K Banda; Allyson K Wood; Kazue Takahashi; Brandt Levitt; Pauline M Rudd; Louise Royle; Jodie L Abrahams; Gregory L Stahl; V Michael Holers; William P Arend
Journal:  Arthritis Rheum       Date:  2008-10

6.  Studies on the antigenic determinants in the self-association of IgG rheumatoid factor.

Authors:  F A Nardella; D C Teller; M Mannik
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

7.  Complement-activating properties of immune complexes are suppressed by IgM rheumatoid factor and enhanced by IgG rheumatoid factor.

Authors:  M Shingu; I Ezaki; M Nobunaga
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

8.  Lack of hidden complement fixing IgM rheumatoid factor in adult seronegative rheumatoid arthritis.

Authors:  D L Robbins; T L Moore
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

9.  Detection of immune complexes in serum of patients with ankylosing spondylitis.

Authors:  V Corrigall; G S Panayi; A Unger; R N Poston; B D Williams
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

10.  IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG.

Authors:  F A Nardella; D C Teller; C V Barber; M Mannik
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.